Envision Pharma Group has appointed Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and Riparian. Siino will lead a team providing commercialization, launch, and revenue management services to pharma and biotech companies.
Life sciences firms look for external support as they get ready to bring therapies to market, particularly when they have yet to build in-house commercial, market access, and revenue management capabilities. Two Labs provides commercialization services and consulting support as companies prepare for and execute launches, while Riparian offers consulting, managed services, and technology to manage and protect revenue as therapies reach patients.
Together, the two businesses give clients a single, connected offering that spans launch and beyond. Under Siino’s leadership, clients will have a dedicated commercial partner who understands their stage of growth and can connect them with the full range of Envision’s capabilities as their needs change.
“Life sciences companies of all sizes need partners who can support them from the very start of their commercial journey,” said Tom Langan, CEO, Envision Pharma Group. “Two Labs and Riparian offer solutions that are in high demand in this market. Leigh Anne combines deep domain expertise, a client-side perspective, and a proven record of driving commercial growth, making her the right leader to strengthen these partnerships and expand our presence in this important segment.”
Siino brings extensive experience across biopharma commercialization, market intelligence, and revenue management. She joins Envision from Spherix Global Insights, a market intelligence firm serving the pharma and biotech sectors, where she was Chief Revenue Officer and led commercial strategy and go-to-market expansion into new therapeutic areas and customer markets. Before that, she was Vice President of Sales at IntegriChain, leading sales strategy and execution across large, midsize, and emerging pharma organizations. Earlier in her career, she held roles at UCB and Merck.
Jenn Lospinoso, President, Riparian, said, “Our clients want a partner who understands the complexities of bringing therapies to market and has the expertise to turn commercialization strategy into meaningful results. Leigh Anne knows this market well, and her leadership will help life sciences companies realize the full benefits of Two Labs’ and Riparian’s integrated solutions.”
Siino adds, “Pharma and biotech companies need partners who move at their pace and grow with them. Two Labs and Riparian together address critical needs from launch through revenue management, backed by Envision’s deep expertise across the entire commercialization life cycle. I’m excited to lead a team focused on helping these companies achieve commercial success and bring their therapies to patients.”
